4-METHYL-1-PHENYL-N-(1,3-THIAZOL-2-YL)-1,4-DIHYDROPYRAZOLO(4,3-C)(1,2)BENZOTHIAZINE-3-CARBOXAMIDE 5,5-DIOXIDE
UNII P86XHN744J
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-methyl-1-phenyl-n-(1,3-thiazol-2-yl)-1,4-dihydropyrazolo(4,3-c)(1,2)benzothiazine-3-carboxamide 5,5-dioxide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P86XHN744J.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 85364-17-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H15N5O3S2 QZOCMCQJCBGPSS-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-methyl-1-phenyl-n-(1,3-thiazol-2-yl)-1,4-dihydropyrazolo(4,3-c)(1,2)benzothiazine-3-carboxamide 5,5-dioxide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.